Cholecystokinin acts through catecholaminergic mechanisms in the hypothalamus to influence ingestive behaviour in the rat

S. H. Tsai, E. Passaro, M. T. Lin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Administration of cholecystokinin (CCK)(0.2-0.6 μg in a volume of 2 μl) into the lateral cerebral ventricle caused a decrease in intake of food but a relative increase in intake of water (or water-to-food ratio) in rats. To determine whether the anorexic actions of CCK were mediated through the hypothalamic nuclei, rats were infused with CCK (0.02-0.12 μg in a volume of 0.5 μl) through previously implanted hypothalamic cannulae. Administration of CCK into the lateral hypothalamus, but not the anterior hypothalamus or ventromedial hypothalamus, caused decreased intake of food and a relative increased intake of water. In addition, the responses induced by injection of CCK into the hypothalamus were completely abolished by selective depletion of catecholamines in the hypothalamus (eg. noradrenaline and dopamine) with intra-hypothalamic injection of 6-hydroxydopamine. Intraperitoneal administration of 0.12 μg of CCK had no effect on the intake of food and water in rats. The data indicate that CCK acts through catecholaminergic mechanisms in the hypothalamus to influence feeding behaviour.

Original languageEnglish
Pages (from-to)1351-1356
Number of pages6
JournalNeuropharmacology
Volume23
Issue number11
DOIs
Publication statusPublished - 1984
Externally publishedYes

Fingerprint

Cholecystokinin
Hypothalamus
Drinking
Eating
Lateral Hypothalamic Area
Anterior Hypothalamus
Cerebral Ventricles
Injections
Lateral Ventricles
Oxidopamine
Feeding Behavior
Catecholamines
Dopamine
Norepinephrine
Food
Water

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Cholecystokinin acts through catecholaminergic mechanisms in the hypothalamus to influence ingestive behaviour in the rat. / Tsai, S. H.; Passaro, E.; Lin, M. T.

In: Neuropharmacology, Vol. 23, No. 11, 1984, p. 1351-1356.

Research output: Contribution to journalArticle

@article{5cf830f99e5f43e9b465858dbf53f183,
title = "Cholecystokinin acts through catecholaminergic mechanisms in the hypothalamus to influence ingestive behaviour in the rat",
abstract = "Administration of cholecystokinin (CCK)(0.2-0.6 μg in a volume of 2 μl) into the lateral cerebral ventricle caused a decrease in intake of food but a relative increase in intake of water (or water-to-food ratio) in rats. To determine whether the anorexic actions of CCK were mediated through the hypothalamic nuclei, rats were infused with CCK (0.02-0.12 μg in a volume of 0.5 μl) through previously implanted hypothalamic cannulae. Administration of CCK into the lateral hypothalamus, but not the anterior hypothalamus or ventromedial hypothalamus, caused decreased intake of food and a relative increased intake of water. In addition, the responses induced by injection of CCK into the hypothalamus were completely abolished by selective depletion of catecholamines in the hypothalamus (eg. noradrenaline and dopamine) with intra-hypothalamic injection of 6-hydroxydopamine. Intraperitoneal administration of 0.12 μg of CCK had no effect on the intake of food and water in rats. The data indicate that CCK acts through catecholaminergic mechanisms in the hypothalamus to influence feeding behaviour.",
author = "Tsai, {S. H.} and E. Passaro and Lin, {M. T.}",
year = "1984",
doi = "10.1016/0028-3908(84)90059-5",
language = "English",
volume = "23",
pages = "1351--1356",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Cholecystokinin acts through catecholaminergic mechanisms in the hypothalamus to influence ingestive behaviour in the rat

AU - Tsai, S. H.

AU - Passaro, E.

AU - Lin, M. T.

PY - 1984

Y1 - 1984

N2 - Administration of cholecystokinin (CCK)(0.2-0.6 μg in a volume of 2 μl) into the lateral cerebral ventricle caused a decrease in intake of food but a relative increase in intake of water (or water-to-food ratio) in rats. To determine whether the anorexic actions of CCK were mediated through the hypothalamic nuclei, rats were infused with CCK (0.02-0.12 μg in a volume of 0.5 μl) through previously implanted hypothalamic cannulae. Administration of CCK into the lateral hypothalamus, but not the anterior hypothalamus or ventromedial hypothalamus, caused decreased intake of food and a relative increased intake of water. In addition, the responses induced by injection of CCK into the hypothalamus were completely abolished by selective depletion of catecholamines in the hypothalamus (eg. noradrenaline and dopamine) with intra-hypothalamic injection of 6-hydroxydopamine. Intraperitoneal administration of 0.12 μg of CCK had no effect on the intake of food and water in rats. The data indicate that CCK acts through catecholaminergic mechanisms in the hypothalamus to influence feeding behaviour.

AB - Administration of cholecystokinin (CCK)(0.2-0.6 μg in a volume of 2 μl) into the lateral cerebral ventricle caused a decrease in intake of food but a relative increase in intake of water (or water-to-food ratio) in rats. To determine whether the anorexic actions of CCK were mediated through the hypothalamic nuclei, rats were infused with CCK (0.02-0.12 μg in a volume of 0.5 μl) through previously implanted hypothalamic cannulae. Administration of CCK into the lateral hypothalamus, but not the anterior hypothalamus or ventromedial hypothalamus, caused decreased intake of food and a relative increased intake of water. In addition, the responses induced by injection of CCK into the hypothalamus were completely abolished by selective depletion of catecholamines in the hypothalamus (eg. noradrenaline and dopamine) with intra-hypothalamic injection of 6-hydroxydopamine. Intraperitoneal administration of 0.12 μg of CCK had no effect on the intake of food and water in rats. The data indicate that CCK acts through catecholaminergic mechanisms in the hypothalamus to influence feeding behaviour.

UR - http://www.scopus.com/inward/record.url?scp=0021739031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021739031&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(84)90059-5

DO - 10.1016/0028-3908(84)90059-5

M3 - Article

C2 - 6441894

AN - SCOPUS:0021739031

VL - 23

SP - 1351

EP - 1356

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 11

ER -